Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression

References

• Bauman BL, Ko JY, Cox S, et al. Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(19):575–581. doi: 10.15585/mmwr.mm6919a2.
   PubMed Web of Science ®Google Scholar
• Howard MM, Mehta ND, Powrie R. Peripartum depression: early recognition improves outcomes. Cleve Clin J Med. 2017;84(5):388–396. doi: 10.3949/ccjm.84a.14060.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR™. Vol. 5th ed., text rev. Washington (DC): American Psychiatric Publishing, Inc.; 2022.
   Google Scholar
• Committee on Clinical Practice Guidelines—Obstetrics. American College of Obstetricians and Gynecologists. Screening and diagnosis of mental health conditions during pregnancy and postpartum: clinical practice guideline #4 [clinical practice guideline no. 4]. Obstet Gynecol. 2023;141(6):1232–1261.
   PubMed Web of Science ®Google Scholar
• Manso-Córdoba S, Pickering S, Ortega MA, et al. Factors related to seeking help for postpartum depression: a secondary analysis of New York city PRAMS data. Int J Environ Res Public Health. 2020;17(24):9328. doi: 10.3390/ijerph17249328.
   PubMed Web of Science ®Google Scholar
• Posmontier B. Functional status outcomes in mothers with and without postpartum depression. J Midwifery Womens Health. 2008;53(4):310–318. doi: 10.1016/j.jmwh.2008.02.016.
   PubMed Web of Science ®Google Scholar
• Kerstis B, Aarts C, Tillman C, et al. Association between parental depressive symptoms and impaired bonding with the infant. Arch Womens Ment Health. 2016;19(1):87–94. doi: 10.1007/s00737-015-0522-3.
   PubMed Web of Science ®Google Scholar
• McLearn KT, Minkovitz CS, Strobino DM, et al. Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. Arch Pediatr Adolesc Med. 2006;160(3):279–284. doi: 10.1001/archpedi.160.3.279.
   PubMed Web of Science ®Google Scholar
• Da Costa D, Dritsa M, Rippen N, et al. Health-related quality of life in postpartum depressed women. Arch Womens Ment Health. 2006;9(2):95–102. doi: 10.1007/s00737-005-0108-6.
   PubMed Web of Science ®Google Scholar
• Vismara L, Rollè L, Agostini F, et al. Perinatal parenting stress, anxiety, and depression outcomes in first-time mothers and fathers: a 3- to 6-months postpartum follow-up study. Front Psychol. 2016;7:938. doi: 10.3389/fpsyg.2016.00938.
   PubMed Web of Science ®Google Scholar
• Slomian J, Honvo G, Emonts P, et al. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health. 2019;15:1745506519844044. doi: 10.1177/1745506519844044.
   Web of Science ®Google Scholar
• Netsi E, Pearson RM, Murray L, et al. Association of persistent and severe postnatal depression with child outcomes. JAMA Psychiatry. 2018;75(3):247–253. doi: 10.1001/jamapsychiatry.2017.4363.
   PubMed Web of Science ®Google Scholar
• Trost S, Beauregard J, Chandra G, et al., editors. Pregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017–2019. In: Centers for disease control and prevention. Atlanta (GA): US Department of Health and Human Services; 2022.
   Google Scholar
• Patterson R, Balan I, Morrow AL, et al. Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions. Neuropsychopharmacology. 2023;49(1):67–72. doi: 10.1038/s41386-023-01721-1.
   PubMed Web of Science ®Google Scholar
• Practice Advisory: Zuranolone for the Treatment of Postpartum Depression [Internet]. 2023. [cited 2023 Dec 13]. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/08/zuranolone-for-the-treatment-of-postpartum-depression.
   Google Scholar
• Committee on Clinical Practice Guidelines—Obstetrics. American College of Obstetricians and Gynecologists. Treatment and management of mental health conditions during pregnancy and postpartum: clinical practice guideline #5. Obstetrics & Gynecology. 2023;141(6):1262–1288.
   PubMed Web of Science ®Google Scholar
• Molyneaux E, Howard LM, McGeown HR, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2014;2014(9):CD002018. doi: 10.1002/14651858.CD002018.pub2.
   PubMedGoogle Scholar
• Sharma V, Sommerdyk C. Are antidepressants effective in the treatment of postpartum depression? A systematic review. Prim Care Companion CNS Disord. 2013;15(6):PCC.13r01529. doi: 10.4088/PCC.13r01529.
   PubMedGoogle Scholar
• Burval J, Kerns R, Reed K. Treating postpartum depression with brexanolone. Nursing. 2020;50(5):48–53. doi: 10.1097/01.NURSE.0000657072.85990.5a.
   PubMedGoogle Scholar
• FDA News Release. FDA approves first oral treatment for postpartum depression [Internet]. US Food and Drug Administration; 2023. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression.
   Google Scholar
• FDA News Release. FDA approves first treatment for post-partum depression [Internet]. US Food and Drug Administration; 2019. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-post-partum-depression.
   Google Scholar
• Meltzer-Brody S, Colquhoun H, Riesenberg R, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. doi: 10.1016/S0140-6736(18)31551-4.
   PubMed Web of Science ®Google Scholar
• Kanes S, Colquhoun H, Gunduz-Bruce H, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017;390(10093):480–489. doi: 10.1016/S0140-6736(17)31264-3.
   PubMed Web of Science ®Google Scholar
• Hoffmann E, Nomikos GG, Kaul I, et al. SAGE-217, a novel GABA(A) receptor positive allosteric modulator: clinical pharmacology and tolerability in randomized phase I dose-finding studies. Clin Pharmacokinet. 2020;59(1):111–120. doi: 10.1007/s40262-019-00801-0.
   PubMed Web of Science ®Google Scholar
• Deligiannidis KM, Meltzer-Brody S, Maximos B, et al. Zuranolone for the treatment of postpartum depression. Am J Psychiatry. 2023;180(9):668–675. doi: 10.1176/appi.ajp.20220785.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi: 10.1136/jnnp.23.1.56.
   PubMed Web of Science ®Google Scholar
• ZURZUVAE [package insert]: full prescribing information. Cambridge (MA): Sage Therapeutics Inc.; Biogen Inc.; 2023.
   Google Scholar
• Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry. 2021;78(9):951–959. doi: 10.1001/jamapsychiatry.2021.1559.
   PubMed Web of Science ®Google Scholar
• Dias S, Welton N, Sutton A, et al. NICE DSU technical support document 2: a general linear modelling framework for pair-wise and network meta-analysis of randomised controlled trials (last updated Sept 2016). 2011 [updated 2011]. Available from: http://www.nicedsu.org.uk.
   Google Scholar
• Dias S, Welton N, Sutton A, et al. NICE DSU technical support document 1: introduction to evidence synthesis for decision making. 2011. [updated April 2012]. Available from: www.nicedsu.org.uk.
   Google Scholar
• Hoaglin DC, Hawkins N, Jansen JP, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value Health. 2011;14(4):429–437. doi: 10.1016/j.jval.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Cooper MC, Kilvert HS, Hodgkins P, et al. Using matching-adjusted indirect comparisons and network meta-analyses to compare efficacy of brexanolone injection with selective serotonin reuptake inhibitors for treating postpartum depression. CNS Drugs. 2019;33(10):1039–1052. doi: 10.1007/s40263-019-00672-w.
   PubMed Web of Science ®Google Scholar
• Reinhart M, Patton C, Chawla A, et al. Treatment of postpartum depression: a systematic literature review. Value Health. 2017;20(9):A717. doi: 10.1016/j.jval.2017.08.3056.
   Google Scholar
• Zhang Q, Dai X, Li W. Comparative efficacy and acceptability of pharmacotherapies for postpartum depression: a systematic review and network meta-analysis. Front Pharmacol. 2022;13:950004. doi: 10.3389/fphar.2022.950004.
   PubMed Web of Science ®Google Scholar
• Kolahdooz G, Vosough I, Sepahi S, et al. The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial. Int Clin Psychopharmacol. 2023;38(1):9–15. doi: 10.1097/YIC.0000000000000426.
   PubMed Web of Science ®Google Scholar
• Gerbasi ME, Meltzer-Brody S, Acaster S, et al. Brexanolone in postpartum depression: post hoc analyses to help inform clinical decision-making. J Womens Health. 2021;30(3):385–392. doi: 10.1089/jwh.2020.8483.
   Web of Science ®Google Scholar
• Gerbasi ME, Eldar-Lissai A, Acaster S, et al. Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton rating scale for depression. Arch Womens Ment Health. 2020;23(5):727–735. doi: 10.1007/s00737-020-01042-y.
   PubMed Web of Science ®Google Scholar
• Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347(9006):930–933. doi: 10.1016/s0140-6736(96)91414-2.
   PubMed Web of Science ®Google Scholar
• Kashani L, Eslatmanesh S, Saedi N, et al. Comparison of saffron versus fluoxetine in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial. Pharmacopsychiatry. 2017;50(2):64–68. doi: 10.1055/s-0042-115306.
   PubMed Web of Science ®Google Scholar
• Khan A, Khan SR, Shankles EB, et al. Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the clinical global impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol. 2002;17(6):281–285. doi: 10.1097/00004850-200211000-00003.
   PubMed Web of Science ®Google Scholar
• Sharp DJ, Chew-Graham C, Tylee A, et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess. 2010;14(43):iii–iiv, ix–xi, 1–153. doi: 10.3310/hta14430.
   PubMed Web of Science ®Google Scholar
• Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997;314(7085):932–936. doi: 10.1136/bmj.314.7085.932.
   PubMed Web of Science ®Google Scholar
• O'Hara MW, Pearlstein T, Stuart S, et al. A placebo controlled treatment trial of sertraline and interpersonal psychotherapy for postpartum depression. J Affect Disord. 2019;245:524–532. doi: 10.1016/j.jad.2018.10.361.
   PubMed Web of Science ®Google Scholar
• Alon DTR, Czysz A, Vera T, et al. Increased placebo response associated with greater frequency of study visits in major depressive disorder (MDD) clinical trials. Poster presented at. the annual scientific meeting of the Academy of Managed Care Pharmacy; San Antonio, TX, March 21-24, 2023.
   Google Scholar
• Krell HV, Leuchter AF, Morgan M, et al. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry. 2004;65(9):1174–1179. doi: 10.4088/jcp.v65n0904.
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Wall MM, Brown PJ, et al. Patient expectancy as a mediator of placebo effects in antidepressant clinical trials. Am J Psychiatry. 2017;174(2):135–142. doi: 10.1176/appi.ajp.2016.16020225.
   PubMed Web of Science ®Google Scholar
• Chen JA, Papakostas GI, Youn SJ, et al. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the hypericum depression trial study group. J Clin Psychiatry. 2011;72(12):1669–1676. doi: 10.4088/JCP.10m06453.
   PubMed Web of Science ®Google Scholar
• Phillippo DM, Ades AE, Dias S, et al. NICE DSU technical support document 18: methods for population-adjusted indirect comparisons in submission to NICE. 2016. [cited 2023 Mar 22]. Available from: http://www.nicedsu.org.uk.
   Google Scholar
• Signorovitch JE, Sikirica V, Erder MH, et al. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research. Value Health. 2012;15(6):940–947. doi: 10.1016/j.jval.2012.05.004.
   PubMed Web of Science ®Google Scholar
• Lyubenova A, Neupane D, Levis B, et al. Depression prevalence based on the edinburgh postnatal depression scale compared to structured clinical interview for DSM DIsorders classification: systematic review and individual participant data meta-analysis. Int J Methods Psychiatr Res. 2021;30(1):e1860.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Lin H, Howell HB, et al. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry. 2008;69(4):659–665. doi: 10.4088/jcp.v69n0420.
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi: 10.1093/biomet/70.1.41.
   Web of Science ®Google Scholar
• Efron BT, R J. An introduction to the bootstrap. Boca Raton (FL): Chapman & Hall CRC; 1993.
   Google Scholar
• Therneau TM, C CS, Atkinson EJ. Adjusted survival curves. 2015. [cited 2023 Mar 22]. Available from: https://cran.r-project.org/web/packages/survival/vignettes/adjcurve.pdf.
   Google Scholar
• Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–691. doi: 10.1016/s0895-4356(97)00049-8.
   PubMed Web of Science ®Google Scholar
• R, Core, Team. R. A language and environment for statistical computing. R Foundation for Statistical Computing. 2017. [cited 2018 Mar 27]. Available from: https://www.R-project.org/.
   Google Scholar
• Rücker G, Schwarzer G, Krahn U, et al. netmeta: network meta-analysis using frequentist methods. 2018. [cited 2018 Jun 19]. Available from: https://CRAN.R-project.org/package=netmeta.
   Google Scholar
• Hantsoo L, Ward-O'Brien D, Czarkowski KA, et al. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology. 2014;231(5):939–948. doi: 10.1007/s00213-013-3316-1.
   PubMed Web of Science ®Google Scholar
• Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry. 2004;65(9):1236–1241. doi: 10.4088/jcp.v65n0913.
   PubMed Web of Science ®Google Scholar
• Sage Therapeutics. A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of SAGE-217 in the treatment of adults with severe postpartum depression. 2022.
   Google Scholar
• Phillippo DM, Dias S, Elsada A, et al. Population adjustment methods for indirect comparisons: a review of national institute for health and care excellence technology appraisals. Int J Technol Assess Health Care. 2019;35(3):221–228. doi: 10.1017/S0266462319000333.
   PubMed Web of Science ®Google Scholar
• Frazer A, Benmansour S. Delayed pharmacological effects of antidepressants. Mol Psychiatry. 2002;7(S1):S23–S28. doi: 10.1038/sj.mp.4001015.
   PubMedGoogle Scholar
• Thomason E, Volling BL, Flynn HA, et al. Parenting stress and depressive symptoms in postpartum mothers: bidirectional or unidirectional effects? Infant Behav Dev. 2014;37(3):406–415. doi: 10.1016/j.infbeh.2014.05.009.
   PubMed Web of Science ®Google Scholar
• Eastwood JG, Jalaludin BB, Kemp LA, et al. Relationship of postnatal depressive symptoms to infant temperament, maternal expectations, social support and other potential risk factors: findings from a large Australian cross-sectional study. BMC Pregnancy Childbirth. 2012;12(1):148. doi: 10.1186/1471-2393-12-148.
   PubMedGoogle Scholar
• Koutra K, Chatzi L, Bagkeris M, et al. Antenatal and postnatal maternal mental health as determinants of infant neurodevelopment at 18 months of age in a mother-child cohort (rhea study) in Crete, Greece. Soc Psychiatry Psychiatr Epidemiol. 2013;48(8):1335–1345. doi: 10.1007/s00127-012-0636-0.
   PubMed Web of Science ®Google Scholar
• Surkan PJ, Ettinger AK, Hock RS, et al. Early maternal depressive symptoms and child growth trajectories: a longitudinal analysis of a nationally representative US birth cohort. BMC Pediatr. 2014;14(1):185. doi: 10.1186/1471-2431-14-185.
   PubMedGoogle Scholar
• Pearson RM, Evans J, Kounali D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry. 2013;70(12):1312–1319. doi: 10.1001/jamapsychiatry.2013.2163.
   PubMed Web of Science ®Google Scholar
• National Institute of Child Health and Human Development. Zuranolone. Bethesda (MD): National Institute of Child Health and Human Development; 2006. [updated 2023 Sep 15; 2024 Mar 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK594292/.
   Google Scholar
• Hafliðadóttir SH, Juhl CB, Nielsen SM, et al. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials. 2021;22(1):493. doi: 10.1186/s13063-021-05454-8.
   PubMed Web of Science ®Google Scholar
• Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338(1):b1147–b1147. doi: 10.1136/bmj.b1147.
   PubMedGoogle Scholar
• Brown JVE, Wilson CA, Ayre K, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2021;2(2):CD013560. doi: 10.1002/14651858.CD013560.pub2.
   PubMedGoogle Scholar
• Bobo WV, Yawn BP. Concise review for physicians and other clinicians: postpartum depression. Mayo Clin Proc. 2014;89(6):835–844. doi: 10.1016/j.mayocp.2014.01.027.
   PubMed Web of Science ®Google Scholar
• Rafferty J, Mattson G, Earls MF, et al. Incorporating recognition and management of perinatal depression into pediatric practice. Pediatrics. 2019;143(1):e20183260. doi: 10.1542/peds.2018-3259.
   PubMed Web of Science ®Google Scholar
• Mori E, Iwata H, Sakajo A, et al. Association between physical and depressive symptoms during the first 6 months postpartum. Int J Nurs Pract. 2017;23(Suppl 1):e12545. doi: 10.1111/ijn.12545.
   Google Scholar
• Machado-Vieira R, Salvadore G, Luckenbaugh DA, et al. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry. 2008;69(6):946–958. doi: 10.4088/jcp.v69n0610.
   PubMed Web of Science ®Google Scholar